Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04375280
Other study ID # RBHP 2019 COSTES
Secondary ID 2019-A01017-50
Status Recruiting
Phase N/A
First received
Last updated
Start date August 27, 2020
Est. completion date September 2031

Study information

Verified date August 2020
Source University Hospital, Clermont-Ferrand
Contact Lise Laclautre
Phone 334.73.754.963
Email promo_interne_drci@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern. Therefore, the exploration of locomotor deficiencies, physical capacities and metabolism of patients with chronic illnesses constitutes a major challenge both for the treatment of causal pathologies, as well as for evaluating the impact of therapeutic interventions, the benefit of which will be an improvement in physical capacities and ultimately mobility. In view of the hypothesis of an increase in the prevalence of mobility disorders in this population, this approach is part of a logic of screening and improving the effectiveness of the care of these patients with a multidisciplinary evaluation of individual risks. The EVALMOB protocol was designed in order to try to determine a standard profile of "dysmobility" in patients with chronic illness


Description:

We propose to constitute a prospective cohort of subjects carrying chronic disease. The objective is to explore all the different components of mobility (balance, muscle force, body composition, walking ability, metabolism, etc.), to assess their impact on the functional capacity of individuals and to identify their potential interactions. Processing this data could ultimately allow the development of a model to determine a composite standard profile of "dysmobility" in patients with chronic disease.

In the present protocol, parameters will be measured on five occasions (at inclusion, at 6 months from the inclusion day, at 1,2 and 5 year(s) from the inclusion day). All tests will be performed on the same day. New assessments will be done on the same principle as the initial evaluation.

Statistical analyses will be carried out using Stata software (version 13, StataCorp, College Station, USA). Data will be described by frequencies and percentages for categorical variables and by means and standard deviation (or median and interquartile range if data are not normally distributed) for continuous variables. The normality of continuous data will be assessed graphically and using the Shapiro-Wilk test. The main analysis will consist in determining patient profiles regarding their mobility. Clustering-type approaches (supervised or not) will be proposed: k-means, vector machine support, machine learning, factor analysis. For example, factor analyses on mixed data will allow the main components of mobility to be characterized. They can be followed by an ascending hierarchical classification in order to determine homogeneous groups of patients.

These groups will be described and compared on the main criteria evaluated using standard statistical tests: chi2 test (or Fisher's exact test if applicable) for the categorical criteria and using an analysis of variance (or Kruskal-Wallis if data are not normally distributed) for continuous criteria. The main analysis will be broken down more specifically for each of the pathologies considered. In addition, the sensitivity to change will be assessed in each pathology and for each assessment criterion. The search for factors related to the evolution of the different criteria will be carried out using usual tests and mixed multivariate models (logistics for categorical / linear criteria for continuous criteria) considering the subject as a random effect, and adjusting on the time criteria (inclusion / follow-up) and the criteria highlighted in the univariate analyses and in light of the elements reported in the literature. A sensitivity analysis will be proposed in order to study the statistical nature of the missing data and to propose, if necessary, the most suitable method of imputing the data: multiple imputation, maximum bias or LOCF in the case of longitudinal data.


Recruitment information / eligibility

Status Recruiting
Enrollment 5000
Est. completion date September 2031
Est. primary completion date September 2030
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Man or woman aged 18 to 90.

- Patients with chronic pathology contributing to impaired mobility.

- Volunteers who have given their written consent.

- Affiliated to French health care system (for France)

Exclusion Criteria:

- Patients suffering from progressive psychiatric pathologies (active psychosis, hallucinations, etc.) or the presence of another serious unstabilized pathology (decompensated heart failure, progressive terminal cancer, etc.).

- People with poorly controlled or unstable cardiovascular disease.

- Major osteoarticular or neurological problems completely preventing the proper performance of the various tests.

- Non-autonomous patient

- Persons under guardianship, curatorship, deprived of liberty or safeguarding justice.

- People excluded from another study.

- Pregnant or lactating women.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Development of a screening algorithm designed to determine a "dysmobility" profile in patients with chronic illness.
Firstly, volunteers will be invited to complete online questionnaires on a secure platform. The mobility assessment will be carried out initially (t1) and up to a maximum of 4 times (t1 to t4) as part of a day hospitalization. Questionnaires will be diverse (SF36, KOOS, HOOS, BROCKER, MNA, TAMPA, etc.) in order to assess several aspects that compose mobility. Physical evaluations will include various validated tests (isokinetic strength measure, TUG, 6MWT, Berg Balance Scale, etc.)

Locations

Country Name City State
France Chu Clermont Ferrand Clermont-Ferrand

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand I-SITE Cap 20-25 project

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary dismobility score calculated from the results reported in secondary outcomes The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles Day 0
Primary dismobility score calculated from the results reported in secondary outcomes The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles Month 6
Primary dismobility score calculated from the results reported in secondary outcomes The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles Year 1
Primary dismobility score calculated from the results reported in secondary outcomes The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles Year 2
Primary dismobility score calculated from the results reported in secondary outcomes The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles Year 5
Secondary The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles Demographics information will be obtained using a single questionnaire including questions on age, gender, qualification, personal work status, ethnicity, life and occupational events. Day 0
Secondary Weight (Kg). Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. Day 0
Secondary Weight (Kg). Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. Month 6
Secondary Weight (Kg). Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. Year 1
Secondary Weight (Kg). Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. Year 2
Secondary Weight (Kg). Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. Year 5
Secondary Height (cm). Height will be measured with a wall mounted tape measure and according to the ISAK recommendations Day 0
Secondary Height (cm). Height will be measured with a wall mounted tape measure and according to the ISAK recommendations Month 6
Secondary Height (cm). Height will be measured with a wall mounted tape measure and according to the ISAK recommendations Year 1
Secondary Height (cm). Height will be measured with a wall mounted tape measure and according to the ISAK recommendations Year 2
Secondary Height (cm). Height will be measured with a wall mounted tape measure and according to the ISAK recommendations Year 5
Secondary Body fat percentage (%). Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). Day 0
Secondary Body fat percentage (%). Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). Month 6
Secondary Body fat percentage (%). Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). Year 1
Secondary Body fat percentage (%). Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). Year 2
Secondary Body fat percentage (%). Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). Year 5
Secondary Waist circumference (cm). Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations Day 0
Secondary Waist circumference (cm). Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations Month 5
Secondary Waist circumference (cm). Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations Year 1
Secondary Waist circumference (cm). Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations Year 2
Secondary Waist circumference (cm). Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations Year 5
Secondary Hip circumference (cm). Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Day 0
Secondary Hip circumference (cm). Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Month 6
Secondary Hip circumference (cm). Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Year 1
Secondary Hip circumference (cm). Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Year 2
Secondary Hip circumference (cm). Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Year 5
Secondary Brachial circumference (cm). Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Day 0
Secondary Brachial circumference (cm). Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Month 6
Secondary Brachial circumference (cm). Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Year 1
Secondary Brachial circumference (cm). Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Year 2
Secondary Brachial circumference (cm). Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. Year 5
Secondary Calf circumference (cm). Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations Day 0
Secondary Calf circumference (cm). Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations Month 6
Secondary Calf circumference (cm). Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations Year 1
Secondary Calf circumference (cm). Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations Year 2
Secondary Calf circumference (cm). Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations Year 5
Secondary Body Mass Index (Kg/m²). BMI will be calculated (weight in kilograms divided by height in meters squared). Day 0
Secondary Body Mass Index (Kg/m²). BMI will be calculated (weight in kilograms divided by height in meters squared). Month 6
Secondary Body Mass Index (Kg/m²). BMI will be calculated (weight in kilograms divided by height in meters squared). Year 1
Secondary Body Mass Index (Kg/m²). BMI will be calculated (weight in kilograms divided by height in meters squared). Year 2
Secondary Body Mass Index (Kg/m²). BMI will be calculated (weight in kilograms divided by height in meters squared). Year 5
Secondary Body composition Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. Day 0
Secondary Body composition Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. Month 6
Secondary Body composition Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. Year 1
Secondary Body composition Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. Year 2
Secondary Body composition Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. Year 5
Secondary T-score (DS). - Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. DAy 0
Secondary T-score (DS). - Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Month 6
Secondary T-score (DS). - Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 1
Secondary T-score (DS). - Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 2
Secondary T-score (DS). - Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 5
Secondary Z-score (DS). Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Day 0
Secondary Z-score (DS). Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Month 6
Secondary Z-score (DS). Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Year 1
Secondary Z-score (DS). Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Year 2
Secondary Z-score (DS). Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Year 5
Secondary Fat mass Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Day 0
Secondary Fat mass Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Month 6
Secondary Fat mass Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 1
Secondary Fat mass Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 2
Secondary Fat mass Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 5
Secondary Fat-free mass (%). : Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Day 0
Secondary Fat-free mass (%). : Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Month 6
Secondary Fat-free mass (%). : Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 1
Secondary Fat-free mass (%). : Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 2
Secondary Fat-free mass (%). : Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 5
Secondary Fat mas index (Kg/m²). Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Day 0
Secondary Fat mas index (Kg/m²). Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Month 6
Secondary Fat mas index (Kg/m²). Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 1
Secondary Fat mas index (Kg/m²). Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 2
Secondary Fat mas index (Kg/m²). Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 5
Secondary Ratio of android to gynoid fat mass. Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Day 0
Secondary Ratio of android to gynoid fat mass. Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Month 6
Secondary Ratio of android to gynoid fat mass. Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Year 1
Secondary Ratio of android to gynoid fat mass. Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Year 2
Secondary Ratio of android to gynoid fat mass. Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer Year 5
Secondary Visceral adipose tissue (Kg). Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Day 0
Secondary Visceral adipose tissue (Kg). Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Month 6
Secondary Visceral adipose tissue (Kg). Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 1
Secondary Visceral adipose tissue (Kg). Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 2
Secondary Visceral adipose tissue (Kg). Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 5
Secondary Fat-free mass index (kg/m²). : Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Day 0
Secondary Fat-free mass index (kg/m²). : Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Month 6
Secondary Fat-free mass index (kg/m²). : Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 1
Secondary Fat-free mass index (kg/m²). : Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 2
Secondary Fat-free mass index (kg/m²). : Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 5
Secondary Appendicular fat-free mass index (Kg/m²). Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Day 0
Secondary Appendicular fat-free mass index (Kg/m²). Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Month 6
Secondary Appendicular fat-free mass index (Kg/m²). Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 1
Secondary Appendicular fat-free mass index (Kg/m²). Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 2
Secondary Appendicular fat-free mass index (Kg/m²). Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 5
Secondary Bone mass (Kg) - Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Day 0
Secondary Bone mass (Kg) - Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Month 6
Secondary Bone mass (Kg) - Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 1
Secondary Bone mass (Kg) - Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 2
Secondary Bone mass (Kg) - Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. Year 5
Secondary Daily caloric intake (Kcal/24h). Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Day 0
Secondary Daily caloric intake (Kcal/24h). Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Month 6
Secondary Daily caloric intake (Kcal/24h). Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 1
Secondary Daily caloric intake (Kcal/24h). Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 2
Secondary Daily caloric intake (Kcal/24h). Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 5
Secondary Daily protein intake (in g and as a percentage of total caloric intake). Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Day 0
Secondary Daily protein intake (in g and as a percentage of total caloric intake). Daily protein intake (in g and as a percentage of total caloric intake). Month 6
Secondary Daily protein intake (in g and as a percentage of total caloric intake). Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 1
Secondary Daily protein intake (in g and as a percentage of total caloric intake). Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 2
Secondary Daily protein intake (in g and as a percentage of total caloric intake). Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 5
Secondary Daily carbohydrate intake (in g and as a percentage of total caloric intake). Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Day 0
Secondary Daily carbohydrate intake (in g and as a percentage of total caloric intake). Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Month 6
Secondary Daily carbohydrate intake (in g and as a percentage of total caloric intake). Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 1
Secondary Daily carbohydrate intake (in g and as a percentage of total caloric intake). Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 2
Secondary Daily carbohydrate intake (in g and as a percentage of total caloric intake). Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 5
Secondary Daily fat intake (in g and as a percentage of total caloric intake). Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Day 0
Secondary Daily fat intake (in g and as a percentage of total caloric intake). Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Month 6
Secondary Daily fat intake (in g and as a percentage of total caloric intake). Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 1
Secondary Daily fat intake (in g and as a percentage of total caloric intake). Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 2
Secondary Daily fat intake (in g and as a percentage of total caloric intake). Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). Year 5
Secondary Nutritional status assessment Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. Day 0
Secondary Nutritional status assessment Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. Month 6
Secondary Nutritional status assessment Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. Year 1
Secondary Nutritional status assessment Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. Year 2
Secondary Nutritional status assessment Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. Year 5
Secondary Risk of undernutrition. Risk of undernutrition will be assessed with the Brocker Questionnaire Day 0
Secondary Risk of undernutrition. Risk of undernutrition will be assessed with the Brocker Questionnaire Month 6
Secondary Risk of undernutrition. Risk of undernutrition will be assessed with the Brocker Questionnaire Year 1
Secondary Risk of undernutrition. Risk of undernutrition will be assessed with the Brocker Questionnaire Year 2
Secondary Risk of undernutrition. Risk of undernutrition will be assessed with the Brocker Questionnaire Year 5
Secondary Basic biology. : Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) Day 0
Secondary Basic biology. : Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) Month 6
Secondary Basic biology. : Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) Year 1
Secondary Basic biology. : Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) Year 2
Secondary Basic biology. : Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) Year 5
Secondary Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm). : Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. Day 0
Secondary Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm). : Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. Month 6
Secondary Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm). : Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. Year 1
Secondary Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm). : Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. Year 2
Secondary Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm). : Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. Year 5
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm). - Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. Day 0
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm). - Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. Month 6
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm). - Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. Year 1
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm). - Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. Year 2
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm). - Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. Year 5
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. Day 0
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. Month 6
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. Year 1
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. Year 2
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. Year 5
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. Day 0
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. Month 6
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. Year 1
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. Year 2
Secondary Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. Year 5
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. Day 0
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. Month 6
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. Year 1
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. Year 2
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. Year 5
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm). - Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. Day 0
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm). - Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. Month 6
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm). - Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. Year 1
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm). - Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. Year 2
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm). - Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. Year 5
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. Day 0
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. Month 6
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. Year 1
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. Year 2
Secondary Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm). Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. Year 5
Secondary Endurance coefficient of the quadriceps muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. Day 0
Secondary Endurance coefficient of the quadriceps muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. Month 6
Secondary Endurance coefficient of the quadriceps muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. Year 1
Secondary Endurance coefficient of the quadriceps muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. Year 2
Secondary Endurance coefficient of the quadriceps muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. Year 5
Secondary Endurance coefficient of the hamstring muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. Day 0
Secondary Endurance coefficient of the hamstring muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. Month 6
Secondary Endurance coefficient of the hamstring muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. Year 1
Secondary Endurance coefficient of the hamstring muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. Year 2
Secondary Endurance coefficient of the hamstring muscles at 180°/s. Endurance coefficient will be estimated as a S Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. Year 5
Secondary Functional ratio Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. Day 0
Secondary Functional ratio Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. Month 6
Secondary Functional ratio Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. Year 1
Secondary Functional ratio Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. Year 2
Secondary Functional ratio Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. Year 5
Secondary Mixed ratio - Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. Day 0
Secondary Mixed ratio - Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. Month 6
Secondary Mixed ratio - Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. Year 1
Secondary Mixed ratio - Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. Year 2
Secondary Mixed ratio - Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. Year 5
Secondary Maximum voluntary hand grip strength (Kg). Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. Day 0
Secondary Maximum voluntary hand grip strength (Kg). Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. Month 6
Secondary Maximum voluntary hand grip strength (Kg). Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. Year 1
Secondary Maximum voluntary hand grip strength (Kg). Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. Year 2
Secondary Maximum voluntary hand grip strength (Kg). Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. Year 5
Secondary Maximum voluntary pinch strength (Kg). Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. Day 0
Secondary Maximum voluntary pinch strength (Kg). Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. Month 6
Secondary Maximum voluntary pinch strength (Kg). Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. Year 1
Secondary Maximum voluntary pinch strength (Kg). Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. Year 2
Secondary Maximum voluntary pinch strength (Kg). Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. Year 5
Secondary Hip passive joint range Hip joint range will be measured with a medical goniometer. Day 0
Secondary Hip passive joint range Hip joint range will be measured with a medical goniometer. Month 6
Secondary Hip passive joint range Hip joint range will be measured with a medical goniometer. Year 1
Secondary Hip passive joint range Hip joint range will be measured with a medical goniometer. Year 2
Secondary Hip passive joint range Hip joint range will be measured with a medical goniometer. Year 5
Secondary Knee passive joint range. Knee joint range will be measured with a medical goniometer. Day 0
Secondary Knee passive joint range. Knee joint range will be measured with a medical goniometer. Month 6
Secondary Knee passive joint range. Knee joint range will be measured with a medical goniometer. Year 1
Secondary Knee passive joint range. Knee joint range will be measured with a medical goniometer. Year 2
Secondary Knee passive joint range. Knee joint range will be measured with a medical goniometer. Year 5
Secondary Ankle passive joint range Ankle joint range will be measured with a medical goniometer. Day 0
Secondary Ankle passive joint range Ankle joint range will be measured with a medical goniometer. Month 6
Secondary Ankle passive joint range Ankle joint range will be measured with a medical goniometer. Year 1
Secondary Ankle passive joint range Ankle joint range will be measured with a medical goniometer. Year 2
Secondary Ankle passive joint range Ankle joint range will be measured with a medical goniometer. Year 5
Secondary Lower and upper limb muscle power assessment (MRC) Lower and upper limb muscle power assessment will be performed by an experienced physician. Day 0
Secondary Lower and upper limb muscle power assessment (MRC) Lower and upper limb muscle power assessment will be performed by an experienced physician. Month 6
Secondary Lower and upper limb muscle power assessment (MRC) Lower and upper limb muscle power assessment will be performed by an experienced physician. Year 1
Secondary Lower and upper limb muscle power assessment (MRC) Lower and upper limb muscle power assessment will be performed by an experienced physician. Year 2
Secondary Lower and upper limb muscle power assessment (MRC) Lower and upper limb muscle power assessment will be performed by an experienced physician. Year 5
Secondary Statokinesigram surface area (mm²) Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. Day 0
Secondary Statokinesigram surface area (mm²) Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. Month 6
Secondary Statokinesigram surface area (mm²) Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. Year 1
Secondary Statokinesigram surface area (mm²) Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. Year 2
Secondary Statokinesigram surface area (mm²) Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. Year 5
Secondary Stabilogram length (mm). Stabilogram length will be measured with the STATIPRO® static posturography platform Day 0
Secondary Stabilogram length (mm). Stabilogram length will be measured with the STATIPRO® static posturography platform Month 6
Secondary Stabilogram length (mm). Stabilogram length will be measured with the STATIPRO® static posturography platform Year 1
Secondary Stabilogram length (mm). Stabilogram length will be measured with the STATIPRO® static posturography platform Year 2
Secondary Stabilogram length (mm). Stabilogram length will be measured with the STATIPRO® static posturography platform Year 5
Secondary Maximal deflection (forward, backward left and right). Maximal deflection will be measured with the STATIPRO® static posturography platform. Day 0
Secondary Maximal deflection (forward, backward left and right). Maximal deflection will be measured with the STATIPRO® static posturography platform. Month 6
Secondary Maximal deflection (forward, backward left and right). Maximal deflection will be measured with the STATIPRO® static posturography platform. Year 1
Secondary Maximal deflection (forward, backward left and right). Maximal deflection will be measured with the STATIPRO® static posturography platform. Year 2
Secondary Maximal deflection (forward, backward left and right). Maximal deflection will be measured with the STATIPRO® static posturography platform. Year 5
Secondary Velocity variations (mm/s). : Velocity variations will be measured with the STATIPRO® static posturography platform. Day 0
Secondary Velocity variations (mm/s). : Velocity variations will be measured with the STATIPRO® static posturography platform. Month 6
Secondary Velocity variations (mm/s). : Velocity variations will be measured with the STATIPRO® static posturography platform. Year 1
Secondary Velocity variations (mm/s). : Velocity variations will be measured with the STATIPRO® static posturography platform. Year 2
Secondary Velocity variations (mm/s). : Velocity variations will be measured with the STATIPRO® static posturography platform. Year 5
Secondary : Romberg ratio according to sway area Romberg ratio will be measured with the STATIPRO® static posturography platform. Day 0
Secondary : Romberg ratio according to sway area Romberg ratio will be measured with the STATIPRO® static posturography platform. Month 6
Secondary : Romberg ratio according to sway area Romberg ratio will be measured with the STATIPRO® static posturography platform. Year 1
Secondary : Romberg ratio according to sway area Romberg ratio will be measured with the STATIPRO® static posturography platform. Year 2
Secondary : Romberg ratio according to sway area Romberg ratio will be measured with the STATIPRO® static posturography platform. Year 5
Secondary Romberg ratio according to center of pressure path length Romberg ratio will be measured with the STATIPRO® static posturography platform. Day 0
Secondary Romberg ratio according to center of pressure path length Romberg ratio will be measured with the STATIPRO® static posturography platform. Month 6
Secondary Romberg ratio according to center of pressure path length Romberg ratio will be measured with the STATIPRO® static posturography platform. Year 1
Secondary Romberg ratio according to center of pressure path length Romberg ratio will be measured with the STATIPRO® static posturography platform. Year 2
Secondary Romberg ratio according to center of pressure path length Romberg ratio will be measured with the STATIPRO® static posturography platform. Year 5
Secondary : Plantar pressure ratio sway area. Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. Day 0
Secondary : Plantar pressure ratio sway area. Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. Month 6
Secondary : Plantar pressure ratio sway area. Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. Year 1
Secondary : Plantar pressure ratio sway area. Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. Year 2
Secondary : Plantar pressure ratio sway area. Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. Year 5
Secondary Plantar pressure ratio length. Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. Day 0
Secondary Plantar pressure ratio length. Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. Month 6
Secondary Plantar pressure ratio length. Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. Year 1
Secondary Plantar pressure ratio length. Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. Year 2
Secondary Plantar pressure ratio length. Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. Year 5
Secondary Walking velocity (cm/s). Walking velocity will be measured with the GAITRite® Electronic Walkway. Day 0
Secondary Walking velocity (cm/s). Walking velocity will be measured with the GAITRite® Electronic Walkway. Month 6
Secondary Walking velocity (cm/s). Walking velocity will be measured with the GAITRite® Electronic Walkway. Year 1
Secondary Walking velocity (cm/s). Walking velocity will be measured with the GAITRite® Electronic Walkway. Year 2
Secondary Walking velocity (cm/s). Walking velocity will be measured with the GAITRite® Electronic Walkway. Year 5
Secondary Cadence (steps/min). : Cadence will be measured with the GAITRite® Electronic Walkway. Day 0
Secondary Cadence (steps/min). : Cadence will be measured with the GAITRite® Electronic Walkway. Month 6
Secondary Cadence (steps/min). : Cadence will be measured with the GAITRite® Electronic Walkway. Year 1
Secondary Cadence (steps/min). : Cadence will be measured with the GAITRite® Electronic Walkway. Year 2
Secondary Cadence (steps/min). : Cadence will be measured with the GAITRite® Electronic Walkway. Year 5
Secondary Step length (left and right foot) (cm) Step length will be measured with the GAITRite® Electronic Walkway. DAy 0
Secondary Step length (left and right foot) (cm) Step length will be measured with the GAITRite® Electronic Walkway. Month 6
Secondary Step length (left and right foot) (cm) Step length will be measured with the GAITRite® Electronic Walkway. Year 1
Secondary Step length (left and right foot) (cm) Step length will be measured with the GAITRite® Electronic Walkway. Year 2
Secondary Step length (left and right foot) (cm) Step length will be measured with the GAITRite® Electronic Walkway. Year 5
Secondary Stride length (cm). Stride length will be measured with the GAITRite® Electronic Walkway. Day 0
Secondary Stride length (cm). Stride length will be measured with the GAITRite® Electronic Walkway. month 6
Secondary Stride length (cm). Stride length will be measured with the GAITRite® Electronic Walkway. year 1
Secondary Stride length (cm). Stride length will be measured with the GAITRite® Electronic Walkway. year 2
Secondary Stride length (cm). Stride length will be measured with the GAITRite® Electronic Walkway. year 5
Secondary Single support time left and right foot (s). Single support time will be measured with the GAITRite® Electronic Walkway. Day 0
Secondary Single support time left and right foot (s). Single support time will be measured with the GAITRite® Electronic Walkway. Month 6
Secondary Single support time left and right foot (s). Single support time will be measured with the GAITRite® Electronic Walkway. Year 1
Secondary Single support time left and right foot (s). Single support time will be measured with the GAITRite® Electronic Walkway. Year 2
Secondary Single support time left and right foot (s). Single support time will be measured with the GAITRite® Electronic Walkway. Year 5
Secondary Double support time (s). : Double support time will be measured with the GAITRite® Electronic Walkway. Day 0
Secondary Double support time (s). : Double support time will be measured with the GAITRite® Electronic Walkway. Month 6
Secondary Double support time (s). : Double support time will be measured with the GAITRite® Electronic Walkway. YEar 1
Secondary Double support time (s). : Double support time will be measured with the GAITRite® Electronic Walkway. Year 2
Secondary Double support time (s). : Double support time will be measured with the GAITRite® Electronic Walkway. Year 5
Secondary Swing time (s). : Swing time will be measured with the GAITRite® Electronic Walkway. Day 0
Secondary Swing time (s). : Swing time will be measured with the GAITRite® Electronic Walkway. Month 6
Secondary Swing time (s). : Swing time will be measured with the GAITRite® Electronic Walkway. Year 1
Secondary Swing time (s). : Swing time will be measured with the GAITRite® Electronic Walkway. Year 2
Secondary Swing time (s). : Swing time will be measured with the GAITRite® Electronic Walkway. Year 5
Secondary Swing phase (as a % of walking cycle). : Swing phase will be measured with the GAITRite® Electronic Walkway. DAy 0
Secondary Swing phase (as a % of walking cycle). : Swing phase will be measured with the GAITRite® Electronic Walkway. Month 6
Secondary Swing phase (as a % of walking cycle). : Swing phase will be measured with the GAITRite® Electronic Walkway. Year 1
Secondary Swing phase (as a % of walking cycle). : Swing phase will be measured with the GAITRite® Electronic Walkway. Year 2
Secondary Swing phase (as a % of walking cycle). : Swing phase will be measured with the GAITRite® Electronic Walkway. Year 5
Secondary Stance phase (as a % of walking cycle). Stance phase will be measured with the GAITRite® Electronic Walkway. Day 0
Secondary Stance phase (as a % of walking cycle). Stance phase will be measured with the GAITRite® Electronic Walkway. Month 6
Secondary Stance phase (as a % of walking cycle). Stance phase will be measured with the GAITRite® Electronic Walkway. Year 1
Secondary Stance phase (as a % of walking cycle). Stance phase will be measured with the GAITRite® Electronic Walkway. Year 2
Secondary Stance phase (as a % of walking cycle). Stance phase will be measured with the GAITRite® Electronic Walkway. Year 5
Secondary Vo2max (maximal oxygen consumption) (mL/Kg/min). : Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Day 0
Secondary Vo2max (maximal oxygen consumption) (mL/Kg/min). : Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Month 6
Secondary Vo2max (maximal oxygen consumption) (mL/Kg/min). : Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 1
Secondary Vo2max (maximal oxygen consumption) (mL/Kg/min). : Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 2
Secondary Vo2max (maximal oxygen consumption) (mL/Kg/min). : Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 5
Secondary Maximum heart rate (bpm). Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Day 0
Secondary Maximum heart rate (bpm). Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Month 6
Secondary Maximum heart rate (bpm). Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 1
Secondary Maximum heart rate (bpm). Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 2
Secondary Maximum heart rate (bpm). Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 5
Secondary Maximum power (Watts). Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Day 0
Secondary Maximum power (Watts). Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Month 6
Secondary Maximum power (Watts). Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 1
Secondary Maximum power (Watts). Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 2
Secondary Maximum power (Watts). Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 5
Secondary Threshold power (Watts). Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Day 0
Secondary Threshold power (Watts). Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Month 6
Secondary Threshold power (Watts). Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 1
Secondary Threshold power (Watts). Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 2
Secondary Threshold power (Watts). Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 5
Secondary Threshold heart rate (bpm). Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. DAy 0
Secondary Threshold heart rate (bpm). Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Month 6
Secondary Threshold heart rate (bpm). Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 1
Secondary Threshold heart rate (bpm). Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 2
Secondary Threshold heart rate (bpm). Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 5
Secondary Forced vital Capacity (L). : Forced vital Capacity will be measured with a spirometry test. Day 0
Secondary Forced vital Capacity (L). : Forced vital Capacity will be measured with a spirometry test. Month 6
Secondary Forced vital Capacity (L). : Forced vital Capacity will be measured with a spirometry test. Year 1
Secondary Forced vital Capacity (L). : Forced vital Capacity will be measured with a spirometry test. Year 2
Secondary Forced vital Capacity (L). : Forced vital Capacity will be measured with a spirometry test. Year 5
Secondary Forced Expiratory volume (L) Forced Expiratory volume will be measured with a spirometry test. Day 0
Secondary Forced Expiratory volume (L) Forced Expiratory volume will be measured with a spirometry test. Month 6
Secondary Forced Expiratory volume (L) Forced Expiratory volume will be measured with a spirometry test. Year 1
Secondary Forced Expiratory volume (L) Forced Expiratory volume will be measured with a spirometry test. Year 2
Secondary Forced Expiratory volume (L) Forced Expiratory volume will be measured with a spirometry test. Year 5
Secondary Tiffeneau ratio (%). Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. Day 0
Secondary Tiffeneau ratio (%). Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. Month 6
Secondary Tiffeneau ratio (%). Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. Year 1
Secondary Tiffeneau ratio (%). Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. Year 2
Secondary Tiffeneau ratio (%). Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. Year 5
Secondary Ventilatory reserve (%). Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Day 0
Secondary Ventilatory reserve (%). Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Month 6
Secondary Ventilatory reserve (%). Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 1
Secondary Ventilatory reserve (%). Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 2
Secondary Ventilatory reserve (%). Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. Year 5
Secondary Physical activity Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) Day 0
Secondary Physical activity Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) Month 6
Secondary Physical activity Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) Year 1
Secondary Physical activity Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) Year 2
Secondary Physical activity Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) Year 5
Secondary Functional capacity timed-up and go Functional capacity will be evaluated using the Timed-Up and Go test. Day 0
Secondary Functional capacity timed-up and go Functional capacity will be evaluated using the Timed-Up and Go test. Month 6
Secondary Functional capacity timed-up and go Functional capacity will be evaluated using the Timed-Up and Go test. Year 1
Secondary Functional capacity timed-up and go Functional capacity will be evaluated using the Timed-Up and Go test. Year 2
Secondary Functional capacity timed-up and go Functional capacity will be evaluated using the Timed-Up and Go test. Year 5
Secondary Functional capacity TDM6 Functional capacity will be evaluated using the 6-minute walk test. Day 0
Secondary Functional capacity TDM6 Functional capacity will be evaluated using the 6-minute walk test. Month 6
Secondary Functional capacity TDM6 Functional capacity will be evaluated using the 6-minute walk test. Year 1
Secondary Functional capacity TDM6 Functional capacity will be evaluated using the 6-minute walk test. Year 2
Secondary Functional capacity TDM6 Functional capacity will be evaluated using the 6-minute walk test. Year 5
Secondary Functional capacity Five Times Sit to Stand test. Functional capacity will be evaluated using the Five Times Sit to Stand test. Day 0
Secondary Functional capacity Five Times Sit to Stand test. Functional capacity will be evaluated using the Five Times Sit to Stand test. Month 6
Secondary Functional capacity Five Times Sit to Stand test. Functional capacity will be evaluated using the Five Times Sit to Stand test. Year 1
Secondary Functional capacity Five Times Sit to Stand test. Functional capacity will be evaluated using the Five Times Sit to Stand test. Year 2
Secondary Functional capacity Five Times Sit to Stand test. Functional capacity will be evaluated using the Five Times Sit to Stand test. Year 5
Secondary Functional capacity SPPB Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. Day 0
Secondary Functional capacity SPPB Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. Month 6
Secondary Functional capacity SPPB Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. Year 1
Secondary Functional capacity SPPB Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. Year 2
Secondary Functional capacity SPPB Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. Year 5
Secondary Functional capacity the mini-BESTest. Functional capacity will be evaluated using the mini-BESTest. Day 0
Secondary Functional capacity the mini-BESTest. Functional capacity will be evaluated using the mini-BESTest. Month 6
Secondary Functional capacity the mini-BESTest. Functional capacity will be evaluated using the mini-BESTest. Year 1
Secondary Functional capacity the mini-BESTest. Functional capacity will be evaluated using the mini-BESTest. Year 2
Secondary Functional capacity the mini-BESTest. Functional capacity will be evaluated using the mini-BESTest. Year 5
Secondary Functional capacity Berg Balance Scale. Functional capacity will be evaluated using the Berg Balance Scale. Day 0
Secondary Functional capacity Berg Balance Scale. Functional capacity will be evaluated using the Berg Balance Scale. Month 6
Secondary Functional capacity Berg Balance Scale. Functional capacity will be evaluated using the Berg Balance Scale. Year 1
Secondary Functional capacity Berg Balance Scale. Functional capacity will be evaluated using the Berg Balance Scale. Year 2
Secondary Functional capacity Berg Balance Scale. Functional capacity will be evaluated using the Berg Balance Scale. Year 5
Secondary Functional capacity 10-meter walk test Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). Day 0
Secondary Functional capacity 10-meter walk test Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). Month 6
Secondary Functional capacity 10-meter walk test Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). Year 1
Secondary Functional capacity 10-meter walk test Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). Year 2
Secondary Functional capacity 10-meter walk test Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). Year 5
Secondary Dyspnea Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. Day 0
Secondary Dyspnea Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. Month 6
Secondary Dyspnea Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. Year 1
Secondary Dyspnea Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. Year 2
Secondary Dyspnea Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. Year 5
Secondary Perceived exertion before, during and after effort Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. DAy 0
Secondary Perceived exertion before, during and after effort Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. Month 6
Secondary Perceived exertion before, during and after effort Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. Year 1
Secondary Perceived exertion before, during and after effort Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. Year 2
Secondary Perceived exertion before, during and after effort Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. Year 5
Secondary Pain : Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. Day 0
Secondary Pain : Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. Month 6
Secondary Pain : Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. Year 1
Secondary Pain : Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. Year 2
Secondary Pain : Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. Year 5
Secondary Sarcopenia risk Sarcopenia risk will be evaluated with the SARC-F Questionnaire. Day 0
Secondary Sarcopenia risk Sarcopenia risk will be evaluated with the SARC-F Questionnaire. Month 6
Secondary Sarcopenia risk Sarcopenia risk will be evaluated with the SARC-F Questionnaire. Year 1
Secondary Sarcopenia risk Sarcopenia risk will be evaluated with the SARC-F Questionnaire. Year 2
Secondary Sarcopenia risk Sarcopenia risk will be evaluated with the SARC-F Questionnaire. Year 5
Secondary Social insecurity Social insecurity will be evaluated with the EPICES Score Questionnaire. Day 0
Secondary Social insecurity Social insecurity will be evaluated with the EPICES Score Questionnaire. Month 6
Secondary Social insecurity Social insecurity will be evaluated with the EPICES Score Questionnaire. Year 1
Secondary Social insecurity Social insecurity will be evaluated with the EPICES Score Questionnaire. Year 2
Secondary Social insecurity Social insecurity will be evaluated with the EPICES Score Questionnaire. Year 5
Secondary Kinesiophobia Kinesiophobia will be evaluated with the TAMPA Scale. Day 0
Secondary Kinesiophobia Kinesiophobia will be evaluated with the TAMPA Scale. Month 6
Secondary Kinesiophobia Kinesiophobia will be evaluated with the TAMPA Scale. Year 1
Secondary Kinesiophobia Kinesiophobia will be evaluated with the TAMPA Scale. Year 2
Secondary Kinesiophobia Kinesiophobia will be evaluated with the TAMPA Scale. Year 5
Secondary Quality of life Quality of life will be evaluated with the 36-Item Short Form Survey. Day 0
Secondary Quality of life Quality of life will be evaluated with the 36-Item Short Form Survey. Month 6
Secondary Quality of life Quality of life will be evaluated with the 36-Item Short Form Survey. Year 1
Secondary Quality of life Quality of life will be evaluated with the 36-Item Short Form Survey. Year 2
Secondary Quality of life Quality of life will be evaluated with the 36-Item Short Form Survey. Year 5
Secondary : Balance confidence in performing various activities Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. Day 0
Secondary : Balance confidence in performing various activities Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. Month 6
Secondary : Balance confidence in performing various activities Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. Year 1
Secondary : Balance confidence in performing various activities Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. Year 2
Secondary : Balance confidence in performing various activities Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. Year 5
Secondary Functioning in regards to activities of daily living. Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. Day 0
Secondary Functioning in regards to activities of daily living. Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. Month 6
Secondary Functioning in regards to activities of daily living. Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. Year 1
Secondary Functioning in regards to activities of daily living. Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. Year 2
Secondary Functioning in regards to activities of daily living. Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. Year 5
Secondary Exhaustion Exhaustion will be evaluated with the FACIT-F Questionnaire. Day 0
Secondary Exhaustion Exhaustion will be evaluated with the FACIT-F Questionnaire. Month 6
Secondary Exhaustion Exhaustion will be evaluated with the FACIT-F Questionnaire. Year 1
Secondary Exhaustion Exhaustion will be evaluated with the FACIT-F Questionnaire. Year 2
Secondary Exhaustion Exhaustion will be evaluated with the FACIT-F Questionnaire. Year 5
Secondary Patient's opinion about their knee and associated problems : Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). Day 0
Secondary Patient's opinion about their knee and associated problems : Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). Month 6
Secondary Patient's opinion about their knee and associated problems : Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). Year 1
Secondary Patient's opinion about their knee and associated problems : Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). Year 2
Secondary Patient's opinion about their knee and associated problems : Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). Year 5
Secondary Patient's opinion about their hip and associated problems Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). Day 0
Secondary Patient's opinion about their hip and associated problems Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). Month 6
Secondary Patient's opinion about their hip and associated problems Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). Year 1
Secondary Patient's opinion about their hip and associated problems Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). Year 2
Secondary Patient's opinion about their hip and associated problems Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). Year 5
Secondary Predicting discharge destination after total joint arthroplasty. : Discharge destination will be evaluated with the Risk Assessment and Prediction Tool (RAPT); Day 0
Secondary Predicting discharge destination after total joint arthroplasty. : Discharge destination will be evaluated with the Risk Assessment and Prediction Tool (RAPT); Month 6
Secondary Physical function in myositis patients Physical function will be evaluated with the Stanford Health Assessment Questionnaire. Day 0
Secondary Physical function in myositis patients Physical function will be evaluated with the Stanford Health Assessment Questionnaire. Month 6
Secondary Physical function in myositis patients Physical function will be evaluated with the Stanford Health Assessment Questionnaire. Year 1
Secondary Physical function in myositis patients Physical function will be evaluated with the Stanford Health Assessment Questionnaire. Year 2
Secondary Physical function in myositis patients Physical function will be evaluated with the Stanford Health Assessment Questionnaire. Year 5
Secondary Quality of life in Parkinson's Disease Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). Day 0
Secondary Quality of life in Parkinson's Disease Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). Month 6
Secondary Quality of life in Parkinson's Disease Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). Year 1
Secondary Quality of life in Parkinson's Disease Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). Year 2
Secondary Quality of life in Parkinson's Disease Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). Year 5
Secondary Actimetry. Actimetry data (energy expenditure, number of steps, sedentary time, total physical activity, etc.) will be obtained with the WGT3X-BT Actigraph inertial sensor unit. during 5 consecutive days after day 0
See also
  Status Clinical Trial Phase
Completed NCT05415774 - Combined Deep Brain Stimulation in Parkinson's Disease N/A
Recruiting NCT04691661 - Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease Phase 2
Active, not recruiting NCT05754086 - A Multidimensional Study on Articulation Deficits in Parkinsons Disease
Completed NCT04045925 - Feasibility Study of the Taïso Practice in Parkinson's Disease N/A
Recruiting NCT04194762 - PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation N/A
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05830253 - Free-living Monitoring of Parkinson's Disease Using Smart Objects
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Recruiting NCT06139965 - Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
Completed NCT04580849 - Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease N/A
Completed NCT04477161 - Effect of Ketone Esters in Parkinson's Disease N/A
Completed NCT03980418 - Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam N/A
Recruiting NCT04788693 - Effects of Gait Rehabilitation With Motor Imagery in People With Parkinson's Disease N/A
Completed NCT04942392 - Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic N/A
Terminated NCT03446833 - LFP Beta aDBS Feasibility Study N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT04997642 - Parkinson's Disease and Movement Disorders Clinical Database
Completed NCT04117737 - A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson N/A